PATENT CLAIM ANALYSIS

Application Number: 15927675
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["424", "133100"]

Abstract:
This disclosure provides anti-CXCR5 antibodies and their use in the amelioration, treatment, or prevention of lupus. The disclosure also provides prophylactic, immunotherapeutic, and diagnostic compositions comprising an anti-CXCR5 antibody, and the use of such anti-CXCR5 antibodies in methods of preventing or treating lupus in mammals, including humans.

Claim (Index 9):
The method of  claim 1 , wherein the antibody or fragment thereof is administered to the patient subcutaneously.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 90.0
- Lexical Diversity: 1.61765
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13794264', '12675799', '13794224', '13794244', '13794281']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.756274700322294
- 35 USC 102 Novelty (BERT): 0.5382507011907096
- Combined Prediction Score: 0.7344723004091357
- Mean Citation Score: 372.564536
- Max Citation Score: 388.645
- Similarity Product: 228.82892261207104

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test